生物制造行业周刊：配套政策持续完善，生物制造进入产业化加速关键期

Key Policies - The Ministry of Industry and Information Technology and the National Health Commission have initiated a call for innovative biomanufacturing technology applications in the food processing sector, focusing on areas such as food raw materials, additives, and related products [1] - Hainan Province has introduced measures to support the high-quality development of the biopharmaceutical industry, including financial rewards for product R&D and clinical trials ranging from 400,000 to 10 million yuan [2][3] - Hainan encourages mergers and acquisitions among local pharmaceutical companies, providing interest subsidies for bank loans related to these activities [2] Key Events - The 2025 China Biomanufacturing Technology Innovation Forum will be held in Changde, Hunan, on September 25-26, aiming to promote deep integration of technology innovation and industry [10][12] - The fourth Synthetic Biology and Green Biomanufacturing Conference was successfully held in Ningbo, highlighting AI technology as a new engine for synthetic biology [21] - A biomanufacturing pilot platform alliance has been launched in Binhai New Area, focusing on fermentation, cell, nucleic acid, and vaccine directions [22] Key Companies - Qilu Pharmaceutical has launched 15 biological drugs, including a globally first PD-1/CTLA-4 dual-function combination antibody, marking a significant achievement in China's biopharmaceutical innovation [25][26] - Shenzhen Jingtai Technology's incubated company, Signet Therapeutics, has been nominated for the 2025 Prix Galien USA for its AI-driven gastric cancer drug, showcasing the potential of AI in drug development [29][30] - Saiye Bio has been recognized for its AI application in antibody drug discovery, reflecting the growing trend of integrating AI in biomanufacturing [46]